HealthInc

HealthInc operates an accelerator program designed to assist health-tech startups and scale-ups in Amsterdam-Zuidoost, Netherlands. Through a rigorous ten-week program at the Amsterdam Health & Technology Center, HealthInc provides early-stage entrepreneurs with essential resources, training, and mentorship tailored specifically for the health and healthcare sectors. This initiative is a collaborative effort involving the Amsterdam Health & Technology Institute, Startup Bootcamp, and the Academic Medical Center in Amsterdam. By leveraging collective experience and specialized support, HealthInc aims to foster the growth and development of innovative health-tech businesses.

Lee Greene

Managing Director

6 past transactions

Neurotops

Pre Seed Round in 2024
Neurotops is pioneering the future of mental health care by leveraging the transformative potential of virtual reality (VR) and artificial intelligence (AI). Our platform offers an innovative approach to mental wellness, combining immersive VR experiences with AI-driven therapeutic sessions to provide accessible, affordable, and anonymous mental health support. Designed to serve a wide range of needs, from individuals seeking self-improvement to those requiring professional psychological intervention, Neurotops makes mental health care available to anyone, anywhere, at any time. Our subscription-based model provides users with unlimited access to a variety of AI-based classes focusing on mindfulness, stress reduction, and cognitive behavioral techniques. For users seeking deeper, personalized support, Neurotops connects them with licensed mental health professionals for one-on-one sessions, facilitated through our secure, VR-enabled platform. With a commitment to removing barriers to mental health services, Neurotops is not just a company but a movement towards a more empathetic and accessible approach to mental wellness. Backed by a team of experts in psychology, technology, and digital health, Neurotops is dedicated to delivering evidence-based, user-centric solutions. Our mission is to empower individuals to take control of their mental health through technology, paving the way for a happier, healthier world.

Superpow!

Pre Seed Round in 2021
Superpow! is an online platform facilitating accessible mental health services. It connects users with therapists matched by cultural background, offering confidential, affordable, and flexible therapy sessions.

Oncochain

Pre Seed Round in 2020
Oncochain is focused on developing a real-world data platform specifically for oncology, aimed at standardizing and aggregating anonymized data from cancer patients. This platform facilitates the generation of valuable analytics that support research initiatives for pharmaceutical companies and enhance value-based care for healthcare providers. Utilizing a proprietary web-based electronic health record system tailored for oncology, Oncochain creates operational data repositories that streamline the flow of information between providers and improve the skills of oncology professionals. The company significantly contributes to research by reducing recruitment times for clinical trials and establishing frameworks for multi-centric study design and implementation. Through its software-as-a-service analytics tool, Oncochain delivers essential real-world data insights to clients, including cancer centers, clinicians, and life sciences organizations, thereby accelerating research and optimizing treatment outcomes.

ApexQubit

Angel Round in 2020
ApexQubit is a biotechnology company focused on leveraging advanced technologies to discover new medicines and enhance human health. By integrating innovative approaches, the company aims to contribute to medical advancements that improve health outcomes. ApexQubit is committed to pushing the boundaries of biotechnological research to address critical health challenges and facilitate the development of effective therapeutic solutions.

Purple Gaze

Funding Round in 2020
Purple Gaze specializes in advancing neuroscience research and diagnosing brain disorders through its innovative eye-tracking solutions. The company develops high-performance eye-tracking software and hardware designed to capture high-quality data efficiently and cost-effectively. Its platform enables researchers to input programming functions and launch graphical user interfaces for experiment design and data analysis directly from the console. This feature facilitates seamless, zero-latency communication between eye-tracking data and the programming environment, thereby enhancing the research process.

Akila Labs

Seed Round in 2019
Akila Labs Inc. is a digital health company that develops an artificial intelligence-based platform focused on diabetes prevention and overall health management. Founded in 2017 and headquartered in New York, the company leverages smart devices, wearables, biosensors, electronic health records, and cloud computing to offer personalized health coaching aimed at reversing pre-diabetes. The platform promotes preventative care through Health as a Service, utilizing behavioral AI to enhance user experiences in health and wellness. Akila Labs aims to address significant healthcare challenges by providing solutions for chronic disease management, weight loss, and telehealth services, thereby enabling clients to deliver tailored health insights and analytics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.